Lexicon Pharmaceuticals Inc (LXRX)
1.64
+0.10
(+6.49%)
USD |
NASDAQ |
May 01, 16:00
1.68
+0.04
(+2.44%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Operations (Quarterly): -50.55M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.55M |
| September 30, 2023 | -41.62M |
| June 30, 2023 | -38.12M |
| March 31, 2023 | -31.61M |
| December 31, 2022 | -21.57M |
| September 30, 2022 | -19.44M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -23.42M |
| December 31, 2021 | -22.83M |
| September 30, 2021 | -17.15M |
| June 30, 2021 | -21.88M |
| March 31, 2021 | -25.16M |
| December 31, 2020 | -34.24M |
| September 30, 2020 | -40.38M |
| June 30, 2020 | -46.30M |
| March 31, 2020 | -22.05M |
| December 31, 2019 | -24.37M |
| September 30, 2019 | 190.70M |
| June 30, 2019 | -26.90M |
| March 31, 2019 | -25.62M |
| December 31, 2018 | -27.13M |
| September 30, 2018 | -22.18M |
| June 30, 2018 | -52.52M |
| March 31, 2018 | -46.78M |
| December 31, 2017 | -33.71M |
| Date | Value |
|---|---|
| September 30, 2017 | -33.96M |
| June 30, 2017 | -32.22M |
| March 31, 2017 | -85.50M |
| December 31, 2016 | -48.79M |
| September 30, 2016 | -35.22M |
| June 30, 2016 | -47.88M |
| March 31, 2016 | -43.74M |
| December 31, 2015 | 265.92M |
| September 30, 2015 | -25.48M |
| June 30, 2015 | -32.18M |
| March 31, 2015 | -23.48M |
| December 31, 2014 | -4.458M |
| September 30, 2014 | -21.19M |
| June 30, 2014 | -19.66M |
| March 31, 2014 | -30.32M |
| December 31, 2013 | -21.74M |
| September 30, 2013 | -23.94M |
| June 30, 2013 | -21.13M |
| March 31, 2013 | -24.27M |
| December 31, 2012 | -20.43M |
| September 30, 2012 | -25.07M |
| June 30, 2012 | -21.96M |
| March 31, 2012 | -27.00M |
| December 31, 2011 | -22.49M |
| September 30, 2011 | -20.22M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-50.55M
Minimum
Dec 2023
190.70M
Maximum
Sep 2019
-17.96M
Average
-24.42M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Windtree Therapeutics Inc | -3.567M |
| Novavax Inc | -176.78M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 51.90M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -162.37M |
| Free Cash Flow Per Share (Quarterly) | -0.2062 |
| Free Cash Flow to Equity (Quarterly) | -50.79M |
| Free Cash Flow Yield | -44.80% |